Inno Supps Inno Shred GLP-1 Review: Stimulant Fat Burner With a GLP-1 Label

Key Takeaways

We compared every disclosed dose with the amount used in human research. Two ingredients match their studies: grains of paradise at 40 mg is the dose that raised energy expenditure in a small trial ( Sugita et al., 2013, Br J Nutr), and caffeine at 250 mg is clearly an active dose. Berberine, chromium and Akkermansia are below their studied amounts, the last by a very large margin. The stimulant combination of caffeine, theobromine and alpha-yohimbine is the formula's most noticeable effect and its main safety consideration. Anyone sensitive to stimulants, or with heart rhythm problems, high blood pressure, anxiety or a pregnancy, should avoid it. If berberine is what interests you, a stimulant-free product at a studied dose costs less; see our GLP-1 supplement guide.

Inno Supps GLP-1 review: the full label

The Supplement Facts panel for Inno Shred GLP-1, as listed by GNC, gives these amounts per two capsules: niacin 15 mg, vitamin B6 5 mg, vitamin B12 50 mcg, chromium (as picolinate) 300 mcg, berberine HCl 500 mg, caffeine 250 mg, L-arabinose (Sukre) 200 mg, theobromine 100 mg, grains of paradise extract (Paradoxine) 40 mg and Akkermansia muciniphila 5 mg. Inno Supps' own page also lists alpha-yohimbine and InnoSlim.

Directions on the GNC listing say to take two capsules once daily, in the morning or early afternoon, 30 to 60 minutes before breakfast or lunch. That timing makes sense for a stimulant product, since afternoon caffeine affects sleep. The Inno Supps product page groups berberine, chromium and L-arabinose as a "GLP-1 cravings control matrix" and the rest as fat-burning support.

Third-party analyses list alpha-yohimbine at 2 mg. InnoSlim is a branded astragalus and Panax notoginseng extract whose amount is not shown on the listings we reviewed. When an ingredient amount is missing, you cannot compare it with research, which is one of the points covered in our supplement label guide.

The B vitamins are present at several times the Daily Value. They are cofactors in energy metabolism, but taking extra does not raise energy in people who are not deficient. They are common in fat-burner formulas because they look substantial on a label.

Dose audit: label amount vs. research amount

The table below compares each disclosed dose with the amount used in the human study most relevant to the product's claims. "Match" means the label dose is in the studied range. "Below" means it is lower than what was tested.

The sections below explain each line. The short version: the stimulants work at the dose given, grains of paradise matches its one trial, and the ingredients most connected to the "GLP-1" name are the ones that fall short.

Berberine at 500 mg

Berberine is the ingredient that justifies the GLP-1 label, and it is under-dosed here. Most clinical trials used 900 to 1,500 mg a day, split into two or three doses with meals. Inno Shred provides 500 mg once a day, before a meal.

A meta-analysis of 14 randomized trials found berberine improved blood glucose and lipids in adults with type 2 diabetes, though the authors rated the overall quality of the trials as low ( Dong et al., 2012, Evid Based Complement Alternat Med). For body weight, a 2026 meta-analysis of 23 trials found an average reduction of 0.88 kg compared with control ( Elahi Vahed et al., 2026, Int J Obes). An earlier meta-analysis reported small reductions in body weight, BMI, waist circumference and C-reactive protein ( Asbaghi et al., 2020, Clin Nutr ESPEN). These are real but modest effects at full trial doses.

The GLP-1 link comes mostly from lab and animal research. In diabetic rats, berberine increased GLP-1 secretion ( Lu et al., 2009, J Endocrinol), and in intestinal cells it triggered GLP-1 release through bitter taste receptor pathways ( Yu et al., 2015, Biochem Pharmacol). How much of that carries over to humans at 500 mg a day is not known.

Taking a second serving to reach a trial dose would also double the caffeine to 500 mg, which exceeds the 400 mg a day the FDA describes as an amount not generally associated with negative effects in healthy adults. Berberine also slows the liver enzymes that clear many drugs, including CYP3A4, CYP2D6 and CYP2C9 ( Guo et al., 2012, Eur J Clin Pharmacol), so check with a pharmacist if you take prescription medicine. More detail is in our berberine interactions guide.

The stimulant stack: caffeine, theobromine and alpha-yohimbine

Each serving combines 250 mg caffeine, 100 mg theobromine and 2 mg alpha-yohimbine. Caffeine raises alertness and slightly increases energy expenditure. Theobromine is a milder cousin found in cocoa. Alpha-yohimbine is an alkaloid related to yohimbine, which can raise heart rate and blood pressure. Together they explain most of what users notice.

A 250 mg dose is roughly two and a half 8-ounce cups of brewed coffee taken at once. For many regular coffee drinkers that is manageable; for people who rarely drink caffeine, it can cause jitteriness, a racing heart, anxiety, stomach upset and poor sleep. If you also drink coffee, tea, energy drinks or a pre-workout, add those amounts together before deciding whether this product fits.

Yohimbine-type alkaloids deserve extra caution because labeling in this category has been unreliable. When researchers analyzed 49 U.S. supplement brands labeled as containing yohimbe or yohimbine, the amount of yohimbine per serving ranged from none detected to 12.1 mg, only 11 brands listed a specific quantity, and most of those labels were inaccurate ( Cohen et al., 2016, Drug Test Anal). That study did not test Inno Shred, but it is a reason to prefer stimulant products with independent testing.

People with high blood pressure, heart rhythm problems, anxiety or panic disorder, thyroid conditions, or who take MAO inhibitors, stimulant medicines or certain antidepressants should not use this formula without medical advice. Pregnant or breastfeeding women should avoid it.

Grains of paradise at 40 mg

This is the one dose on the label that matches a published trial exactly. In 19 healthy young men, a single 40 mg dose of grains of paradise extract increased whole-body energy expenditure within two hours, but only in the 12 men whose PET scans showed active brown fat. Men without detectable brown fat had no increase.

Sugita and colleagues measured brown adipose tissue activity with FDG-PET after cold exposure, then tested the extract against placebo in a crossover design ( Sugita et al., 2013, Br J Nutr). The finding is interesting because it suggests the extract works through brown fat thermogenesis. The limits are just as clear: one dose, young men, and an increase in calories burned that depends on having active brown fat. Brown fat activity tends to be lower in older adults and in people with higher body fat, who are often the target market for fat burners.

A follow-up study from the same group gave the extract daily and reported increased whole-body energy expenditure and less visceral fat ( Sugita et al., 2014, J Nutr Sci Vitaminol). Those results are promising but have not been confirmed in larger trials, and no study has tested grains of paradise for appetite or GLP-1.

Chromium and L-arabinose: the "cravings" ingredients

Chromium picolinate reduced food intake and fat cravings in a trial of 42 overweight women with carbohydrate cravings, but at 1,000 mcg a day for 8 weeks, more than three times the 300 mcg here. L-arabinose blunts the blood sugar rise from table sugar by slowing its digestion, so its value depends on how much sugar is in the meal you eat.

In the chromium study, women taking chromium picolinate ate less at measured meals, reported less hunger and fewer fat cravings, and showed a trend toward lower body weight that did not reach statistical significance ( Anton et al., 2008, Diabetes Technol Ther). Inno Shred's 300 mcg is a common supplement dose, but it has not been shown to produce the same effect.

L-arabinose inhibits sucrase, the enzyme that splits table sugar. Studies show it reduces glucose and insulin responses to sucrose-containing drinks, and that the effect is weaker when the meal also contains starch and fat ( Pol et al., 2022, Foods). Taking it before breakfast or lunch makes sense only if that meal contains a meaningful amount of added sugar. It does not act on GLP-1 directly.

Akkermansia at 5 mg

Akkermansia muciniphila is a gut bacterium with interesting human data, but the amount in Inno Shred bears no relation to the studies. The human trial used 10 billion bacteria a day, and a milligram figure on a label does not tell you how many live or intact cells are present.

In a proof-of-concept trial, 32 overweight or obese adults with insulin resistance took live or pasteurized Akkermansia for three months. The pasteurized form improved insulin sensitivity and lowered insulin and total cholesterol compared with placebo, with small decreases in body weight and fat mass ( Depommier et al., 2019, Nat Med). The GLP-1 connection comes from mouse work showing that a protein Akkermansia secretes, called P9, triggers GLP-1 release ( Yoon et al., 2021, Nat Microbiol).

Probiotic doses are normally given as colony-forming units or, for some products, active fluorescent units. Akkermansia is also killed by oxygen, so products built around it use special manufacturing and often refrigeration. A 5 mg inclusion with no count in a room-temperature stimulant capsule is not comparable. Our Pendulum GLP-1 Probiotic review shows what an Akkermansia-focused product looks like.

Night Shred GLP-1 and the stack

Inno Supps also sells Night Shred GLP-1, a bedtime capsule with 500 mg GABA, 500 mg L-arabinose, 200 mg berberine, 200 mg ashwagandha, 30 mg grains of paradise, 15 mg saffron, 5 mg Akkermansia and 3 mg melatonin, and Trim Biome GLP-1, a gut formula with Akkermansia, berberine and pre-, pro- and postbiotics. The company markets the three together.

Taking Inno Shred and Night Shred together brings daily berberine to 700 mg, still below most trial doses. It also means taking melatonin nightly, which many people do not need, and ashwagandha, which is not suitable for everyone; our ashwagandha article covers who should avoid it. The Night Shred product page lists it at $55.99 on subscription.

Buying all three at around $56 to $70 each puts the monthly cost well above a standalone berberine product. Before buying a stack, decide which single effect you actually want, such as stimulant energy, better sleep or a berberine dose, and buy the simplest product that delivers it.

Who should consider it and who should skip it

Inno Shred GLP-1 makes the most sense for healthy adults who already tolerate caffeine well and want a pre-meal stimulant product with some berberine included. It makes little sense for anyone looking for a GLP-1 drug alternative, anyone who wants berberine without stimulants, or anyone with heart, blood pressure, anxiety or sleep problems.

Prescription GLP-1 medicines work by activating the GLP-1 receptor continuously and require a clinician's evaluation. A supplement that combines stimulants with a partial dose of berberine works by different, weaker mechanisms. Expect energy and some appetite suppression from the caffeine, and judge the product on that basis.

For other products in this category, compare our reviews of Lemme GLP-1 Daily and Bioma GLP-1 Booster, neither of which relies on stimulants.

What "GLP-1" on a supplement label means under FDA rules

Supplements may describe effects on normal body structure or function, such as supporting healthy appetite or metabolism, if they carry the FDA disclaimer. They may not claim to treat or prevent a disease. "GLP-1" in a product name is not regulated as a claim by itself, which is why the term now appears on products with very different ingredients.

The rules for structure/function statements are in 21 CFR 101.93. Phrases such as "supports healthy GLP-1 activity" stay within those rules because they describe a normal hormone rather than a disease. The practical problem is that the name invites comparison with prescription GLP-1 drugs, which are approved for specific medical uses after large clinical trials. A supplement carrying the same three letters has not gone through any of that.

A useful habit is to ignore the name and read the panel. In this product, the panel says "stimulant fat burner with a partial dose of berberine." That description, not the name, tells you what to expect. The same habit applies to every product in the category; our guide on reading supplement labels shows how.

How to use it more safely if you try it

Start with one capsule rather than two to see how you handle the stimulants, take it before noon, skip other caffeine that day, and do not combine it with other fat burners or pre-workouts. Stop if you notice a racing or irregular heartbeat, chest discomfort, dizziness, severe anxiety or trouble sleeping.

Half a serving gives about 125 mg of caffeine and half of each other ingredient. That is a reasonable test dose for anyone who is not a heavy coffee drinker. Taking it in the morning keeps most of the caffeine out of your system by bedtime. Many people underestimate how much caffeine they already get from coffee, tea, soda and energy drinks, so count everything for a day before adding this.

Check your blood pressure before and after a week of use if you have a home monitor, especially if your readings run high. Stimulant formulas can raise blood pressure and heart rate in some people. If you take any prescription medicine, show the label to a pharmacist before starting; berberine's effect on liver enzymes ( Guo et al., 2012, Eur J Clin Pharmacol) and the stimulants' effects on heart rate both matter for drug interactions.

Do not take it within a few hours of exercise in hot weather without enough fluids, and avoid it entirely if you are pregnant, breastfeeding, under 18, or have a heart condition, high blood pressure, an anxiety disorder or a thyroid disorder.

What the berberine and stimulants can realistically do

Expect more alertness and some appetite suppression from the caffeine within an hour, and a modest metabolic contribution from berberine over months. Do not expect the kind of weight change seen with prescription GLP-1 drugs. Meta-analyses put berberine's average weight effect at under a kilogram.

Caffeine raises energy expenditure slightly and can reduce appetite for a few hours, but people adapt to regular use, and the effect on long-term weight is small. Berberine's average effect across 23 trials was a 0.88 kg reduction in body weight compared with control ( Elahi Vahed et al., 2026, Int J Obes), and those trials mostly used higher doses than this product. Grains of paradise raised calorie burn in men with active brown fat in a single-dose study ( Sugita et al., 2013, Br J Nutr), which is promising but not yet a proven weight-loss effect.

Put together, the formula can make a calorie-controlled diet feel easier for some people because of the stimulants. It is not a replacement for that diet, and it is not comparable to a medicine that activates the GLP-1 receptor continuously. Our GLP-1 weight loss overview explains how the prescription drugs work and what results look like in trials.

Green coffee bean extract: where the caffeine comes from

The 250 mg of caffeine in Inno Shred comes from green coffee bean extract, meaning unroasted coffee beans. The caffeine is chemically the same as in a cup of coffee. Green coffee extract also contains chlorogenic acids, which are often marketed for weight, but the label does not state how much is present.

Caffeine from a plant extract is sometimes described as gentler than synthetic caffeine anhydrous. The molecule is identical, so any difference in how it feels comes from the dose, the timing and whatever else is in the capsule. Two hundred and fifty milligrams in one dose will feel strong to anyone who does not drink much coffee.

Chlorogenic acids are the main polyphenols in unroasted coffee and have been studied for blood sugar and weight with mixed results, mostly using standardized extracts at stated percentages. Because Inno Shred lists the extract only as a caffeine source, you cannot tell how much chlorogenic acid each serving delivers. If that ingredient interests you, look for a label that gives its percentage.

Frequently asked questions

How much caffeine is in Inno Shred GLP-1?

250 mg per two-capsule serving, from green coffee bean extract, plus 100 mg of theobromine.

Does Inno Shred GLP-1 contain GLP-1?

No. It contains berberine, stimulants, chromium, L-arabinose, grains of paradise, a small amount of Akkermansia and B vitamins. No supplement contains a GLP-1 drug.

Can I take it with coffee?

One serving already equals about two and a half cups of coffee. Adding more caffeine raises the risk of jitters, palpitations and poor sleep. Keep your daily total in mind.

Can I take it with a prescription GLP-1 medicine?

Ask your prescriber. Stimulants can worsen nausea, and berberine can add to glucose-lowering effects and affect how other drugs are metabolized.

Is it third-party certified?

The listings we reviewed do not show a USP, NSF or sport certification for this product. Our testing guide explains what each seal checks.

References

1. Dong H, Wang N, Zhao L, et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012;2012:591654. PubMed 23118793
2. Sugita J, Yoneshiro T, Hatano T, et al. Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in men. Br J Nutr. 2013;110(4):733-8. PubMed 23308394
3. Elahi Vahed I, Shahir-Roudi E, Nojumi S, et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026;50(1):53-73. PubMed 41310257
4. Asbaghi O, Ghanbari N, Shekari M, et al. The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2020;38:43-49. PubMed 32690176
5. Lu SS, Yu YL, Zhu HJ, et al. Berberine promotes glucagon-like peptide-1 (7-36) amide secretion in streptozotocin-induced diabetic rats. J Endocrinol. 2009;200(2):159-65. PubMed 18996945
6. Yu Y, Hao G, Zhang Q, et al. Berberine induces GLP-1 secretion through activation of bitter taste receptor pathways. Biochem Pharmacol. 2015;97(2):173-7. PubMed 26206195
7. Guo Y, Chen Y, Tan ZR, et al. Repeated administration of berberine inhibits cytochromes P450 in humans. Eur J Clin Pharmacol. 2012;68(2):213-7. PubMed 21870106
8. Cohen PA, Wang YH, Maller G, et al. Pharmaceutical quantities of yohimbine found in dietary supplements in the USA. Drug Test Anal. 2016;8(3-4):357-69. PubMed 26391406
9. Sugita J, Yoneshiro T, Sugishima Y, et al. Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humans. J Nutr Sci Vitaminol (Tokyo). 2014;60(1):22-7. PubMed 24759256
10. Anton SD, Morrison CD, Cefalu WT, et al. Effects of chromium picolinate on food intake and satiety. Diabetes Technol Ther. 2008;10(5):405-12. PubMed 18715218
11. Pol K, Puhlmann ML, Mars M. Efficacy of L-Arabinose in Lowering Glycemic and Insulinemic Responses: The Modifying Effect of Starch and Fat. Foods. 2022;11(2). PubMed 35053889
12. Depommier C, Everard A, Druart C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med. 2019;25(7):1096-1103. PubMed 31263284
13. Yoon HS, Cho CH, Yun MS, et al. Akkermansia muciniphila secretes a glucagon-like peptide-1-inducing protein that improves glucose homeostasis and ameliorates metabolic disease in mice. Nat Microbiol. 2021;6(5):563-573. PubMed 33820962
14. GNC listing. www.gnc.com
15. Inno Supps product page. www.innosupps.com
16. FDA describes. www.fda.gov
17. Night Shred product page. www.innosupps.com
18. 21 CFR 101.93. www.ecfr.gov